glp 1 market size share of GLP-1 RAs in 2016 and 2017 GLP-1 Receptor Agonist Market Forecast
Description
These agents have also demonstrated additional metabolic benefits such as delayed gastric emptying and reduced appetite, which contribute to improved overall glycaemic outcomes and cardiometabolic health 7
Other factors, such as participants health conditions, weight loss and metabolic improvements, may have influenced the results, researchers noted
LegitScript Certification: The Gala GLP-1 website displays a LegitScript verification seal
Compounded tirzepatide is made in the U.S
with a safety profile consistent with prior danuglipron studies including no liver enzyme elevations observed in more than 1,400 study participants
